Jonathan Moore, Ph.D.

Jonathan Moore, Ph.D., is Founder and Scientific Advisor at Rectify Pharmaceuticals, where he previously served as Chief Scientific Officer. Prior to starting Rectify, Jon was a Founding Scientist at Vertex Pharmaceuticals, where he spent over 27 years as a Structural Biologist, leading early discovery efforts across multiple disease areas, including anti-infectives, oncology, pain and cystic fibrosis. From 2018-2020, Jon was a Visiting Scientist and Principal Investigator in the Department of Biology at MIT, where his research focused on the structural and mechanistic basis of ABC transporter dysfunction in rare disease. Jon obtained his B.A. and Ph.D. in Biophysics from the University of Pennsylvania and postdoctoral training at the Scripps Research Institute and at the ETH-Zürich, where he was a Fogarty Fellow.